tirzepatide discontinuation Possible Attenuation of Early Weight Loss During Therapy in a Patient Treated With Levosulpiride: A Case Report and Mechanistic Hypothesis Real-World Results of Obesity Pharmacotherapy

Learn about the mechanisms, clinical evidence, expected timeline, and metabolic effects of this FDA-approved weight management medication.

Surgical options are also available.

Get expert tips on enjoying this snack safely & managing diet on GLP-1 medications

Most people see measurable weight loss within 46 weeks of starting semaglutide therapy, though individual timelines vary based on metabolic factors and dose escalation

Learn the key differences between 503A and 503B compounding facilities, their regulations, and how each supports safe, compliant pharmaceutical compounding.

GLP-1 patches are popping up everywhere online, promising needle-free weight loss support and an easy alternative to injections